Suppliers / Ferron Par Pharmaceuticals

Ferron Par Pharmaceuticals

Indonesia Updated 9 July 2026

Ferron Par Pharmaceuticals is a finished-dose manufacturer based in Indonesia. It appears in 171 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Customs aggregates show $1.2M of exports covering 21 molecules to 2 destinations in 2025.

0
active US DMFs
0
valid CEPs
2
registered plants
171
filings across 1 regulators

Registered plants

Site FDA FEI
KAB. BEKASI, Indonesia Not on file
-, Indonesia Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
BPOM (ID) 171 None

Scale

Year Revenue Exports Destinations
2025 Not reported $1.2M 2
2024 Not reported $283K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Ferron Par Pharmaceuticals

Does Ferron Par Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Ferron Par Pharmaceuticals. It does have 171 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Ferron Par Pharmaceuticals manufacture?
2 registered sites are on record, in Indonesia (Kab. Bekasi and -). Every site is listed on this page with the register it came from.
Where does Ferron Par Pharmaceuticals file?
Filings are on record with BPOM (ID), 171 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Ferron Par Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Dankos Farma also in Indonesia Dexa Medica also in Indonesia Fonko International Pharmaceuticals also in Indonesia Medikon Prima Laboratories also in Indonesia Meiji Indonesian Pharmaceutical Industries also in Indonesia

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts